Shanghai RAAS Blood Products Co Ltd 002252.SZ

Last Updated: May 15, 12:00 AM·SZSE

002252.SZ Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: March 27, 2025

Report Source: 2024 3rd Quarter Report

Shanghai RAAS Blood Products Co Ltd

Shanghai RAAS Blood Products Co Ltd. Stock Analysis 002252.SZ

China Health Care Mid Cap Report:
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. The company is headquartered in Shanghai, Shanghai and currently employs 4,045 full-time employees. The company went IPO on 2008-06-23. The firm's main products include human albumin, intravenous human immunoglobulin, specific immunoglobulin and human coagulation factor products. The firm sells its products in the domestic market and overseas markets.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.